Collegium (COLL) director sells shares, exercises options and receives RSU grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Collegium Pharmaceutical director John Gordon Freund reported several equity transactions. On May 15, 2026, he sold 4,127 shares of common stock in an open-market trade at $34.54 per share and exercised stock options to acquire 8,700 shares at $16.49 per share. Following these transactions, he directly holds 83,972 common shares. On May 14, 2026, he also received a grant of 8,741 restricted stock units (RSUs), which vest on the earlier of May 14, 2027 or the company’s 2027 annual meeting, subject to continued board service. In addition, filings show indirect holdings of 23,129 shares through John Freund Family Partnership IV, L.P. and 8,625 shares through Skyline Venture Management V, LLC, where he shares voting and investment power and disclaims beneficial ownership beyond his proportionate pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,127 shares ($142,547)
Net Sell
6 txns
Insider
Freund John Gordon
Role
null
Sold
4,127 shs ($143K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 8,700 | $0.00 | -- |
| Exercise | Common Stock | 8,700 | $16.49 | $143K |
| Sale | Common Stock | 4,127 | $34.54 | $143K |
| Grant/Award | Common Stock | 8,741 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 0 shares (Direct, null);
Common Stock — 88,099 shares (Direct, null);
Common Stock — 23,129 shares (Indirect, By: John Freund Family Partnership IV, L.P.)
Footnotes (1)
- Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock. The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein. The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The Reporting Person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein. The option is fully vested and exercisable.
Key Figures
Open-market sale: 4,127 shares at $34.54
Option exercise: 8,700 shares at $16.49
Direct holdings after transactions: 83,972 shares
+4 more
7 metrics
Open-market sale
4,127 shares at $34.54
Common Stock sale on May 15, 2026
Option exercise
8,700 shares at $16.49
Exercise of Stock Option (Right to Purchase) on May 15, 2026
Direct holdings after transactions
83,972 shares
Common Stock directly owned following reported transactions
RSU grant
8,741 RSUs
Granted May 14, 2026, vesting by May 14, 2027 or 2027 annual meeting
Indirect holdings via family partnership
23,129 shares
Common Stock held by John Freund Family Partnership IV, L.P.
Indirect holdings via Skyline
8,625 shares
Common Stock held by Skyline Venture Management V, LLC
Option exercise price
$16.49 per share
Conversion or exercise price of fully exercised option
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Purchase), pecuniary interest, beneficial ownership, +1 more
5 terms
restricted stock units ("RSUs") financial
"Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Purchase) financial
"security_title": "Stock Option (Right to Purchase)""
pecuniary interest financial
"disclaims beneficial ownership of the shares ... except to the extent of his proportionate pecuniary interest therein"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the shares held by Freund LP..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
voting and investment power financial
"These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC."
FAQ
What did Collegium Pharmaceutical (COLL) director John Gordon Freund sell in this Form 4?
Director John Gordon Freund sold 4,127 shares of Collegium Pharmaceutical common stock at $34.54 per share on May 15, 2026. This open-market sale left him with a substantial remaining direct holding reported in the filing.
Did the COLL director exercise stock options in this Form 4 filing?
Yes. John Gordon Freund exercised a stock option to acquire 8,700 shares of Collegium common stock at an exercise price of $16.49 per share. After this exercise, the related option position was fully used and no derivative balance remained.
What restricted stock units (RSUs) were granted to the COLL director?
On May 14, 2026, John Gordon Freund received 8,741 RSUs, each representing one share of Collegium common stock. These RSUs vest on the earlier of May 14, 2027 or the 2027 annual shareholder meeting, conditioned on continued board service.